Synopsis
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Episodes
-
Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy
30/03/2023 Duration: 37minDid you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies? Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395
-
Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases
29/03/2023 Duration: 34minWhat is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect? Credit available for this activity expires: 3/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990193?ecd=bdc_podcast_libsyn_mscpedu
-
Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch
29/03/2023 Duration: 01h01minDo you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts. Credit available for this activity expires: 28/03/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990120?ecd=bdc_podcast_libsyn_mscpedu
-
Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies
28/03/2023 Duration: 34minDo you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[ArticleID]?src=mkm_podcast_addon_989801
-
Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies
27/03/2023 Duration: 17minDid you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu
-
Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm
27/03/2023 Duration: 36minDo you know which you should be treating first -- the systemic mastocytosis (SM) or the associated hematological neoplasm (AHN)? Credit available for this activity expires: 3/24/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990024?ecd=bdc_podcast_libsyn_mscpedu
-
Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?
24/03/2023 Duration: 18minWho should be taking a glucagon-like peptide-1 (GLP-1) receptor agonist (RA)? Join Drs Bain and Lin to find out. Credit available for this activity expires: 3/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989998?ecd=bdc_podcast_libsyn_mscpedu
-
Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight
23/03/2023 Duration: 21minDo you know the latest information about dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk? Drs Navar and Ray discuss. Credit available for this activity expires: 03/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[989864]?ecd=bdc_podcast_libsyn_mscpedu
-
What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?
16/03/2023 Duration: 37minDid you know that early diabetic kidney disease may reduce the life expectancy of patients by 16 years? Credit available for this activity expires: 3/14/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989288?ecd=bdc_podcast_libsyn_mscpedu
-
Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?
16/03/2023 Duration: 27minPARP inhibitors, CDK4/6 inhibitors, immunotherapy, and SERDS: Can you select optimal treatments for early breast cancer (EBC)? And what might be the consensus at St. Gallen? Credit available for this activity expires: 03/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989483?ecd=bdc_podcast_libsyn_mscpedu
-
Pros and Cons of COVID-19 Vaccination in Children: Weighing the Evidence
02/03/2023 Duration: 38minAre you up to date on COVID-19 vaccination in children? Credit available for this activity expires: 01/03/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988590?ecd=bdc_podcast_libsyn_mscpedu
-
The Road to Safety: Understanding the Common and Less Common Side Effects of COVID-19 and Other Vaccines
28/02/2023 Duration: 38minDo you know what are common and less common adverse events (AEs) following immunization? Credit available for this activity expires: 02/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988364?ecd=bdc_podcast_libsyn_mscpedu
-
Recovering Immune Responses in Heavily Treatment-Experienced HIV-Positive Individuals
14/02/2023 Duration: 16minThis educational activity is intended for an international audience of non-US HIV physicians, infectious disease (ID) physicians, and primary care providers (PCPs). Credit available for this activity expires: 2/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987954?src=mkm_podcast_addon_987954
-
COVID-19 Immunization in Oncology and Stem Cell Transplant Settings: Experts Provide Practical Guidance
13/02/2023 Duration: 33minDid you know that many patients with malignancy have insufficient benefit from 2 doses of COVID-19 vaccines? Join this discussion and see how their outcomes can be improved. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987844?src=mkm_podcast_addon_987844
-
Chronic Kidney Disease – Looking Beyond Diabetes: Expert Interpretation of Latest Evidence From Kidney Outcome Trials
08/02/2023 Duration: 15minHow often should you be monitoring kidney function in a patient with an estimated glomerular filtration rate (eGFR) of 50 mL/min/1.73 m2 and a urine albumin-to-creatinine ratio (UACR) above 30 mg/g? Credit available for this activity expires: 2/7/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987836?src=mkm_podcast_addon_987836
-
Dengue Immunization: Special Populations
03/02/2023 Duration: 33minDo you know how dengue vaccines can protect special populations and be used during outbreaks? Credit available for this activity expires: 02/01/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987640?ecd=bdc_podcast_libsyn_mscpedu
-
Evolving Hesitancies and Objections to COVID-19 Booster Shots: Separating Facts From Fiction
31/01/2023 Duration: 40minAre you prepared to address your patients’ hesitancy and misinformation about COVID-19 booster shots? Credit available for this activity expires: 01/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987018?ecd=bdc_podcast_libsyn_mscpedu
-
Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications
31/01/2023 Duration: 33minWill the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer? Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987087?src=mkm_podcast_addon_987087
-
Early-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment Landscape
26/01/2023 Duration: 36minDid you know that there are now promising perioperative immunotherapies available for your patients with early-stage NSCLC? Credit available for this activity expires: 01/24/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987316?ecd=bdc_podcast_libsyn_mscpedu
-
Advanced Age-Related Macular Degeneration: How to Use Imaging to Screen and Monitor Patients
23/01/2023 Duration: 34minA quarter of people aged over 60 have early or intermediate age-related macular degeneration (AMD). Do you know how to assess these patients and determine follow-up schedules? Credit available for this activity expires: 01/19/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987083?ecd=bdc_podcast_libsyn_mscpedu